Keywords
Violacein
tuberculosis
antimycobacterial
in vitro
Chromobacterium violaceum
Mycobacterium tuberculosis
tuberculosis
antimycobacterial
in vitro
Chromobacterium violaceum
Mycobacterium tuberculosis
How to Cite
1.
Olivia de Souza A, Cristina Girello Aily D, Nakamura Sato D, Durán N. In vitro Activity of violacein against Mycobacterium tuberculosis H37Ra. Rev Inst Adolfo Lutz [Internet]. 1999 Jun. 30 [cited 2024 May 18];58(1):59-62. Available from: https://periodicos.saude.sp.gov.br/RIAL/article/view/36676
Abstract
In this study is are reporting the antimycobacterial activity of violacein, 3[1,2- Dihydro-5-(5-hydroxy-1 H-indole-3-y1)-2-oxo-3H -pyrrol-3-ylidene] 1,3-dihydro- 2Hindole-z-one, against the M. tuberculosis H37 Ra strain. The violacein showed antimycobacterial action in vitro with the minimal inhibitory concentration (MIC) of 64 ug/ml. and minima1 bactericida1 concentration (MBC) of 128 ug/ml., These values are comparable with those from literature for pyrazinamide.
References
1. BARBACHYN, M.R.; HUTCHINSON, D. K.; BRICKNER, S.J.; CYNAMON, M.H.; KILBURN, J.O.; KLEMENS, S.P.; GLICKMAN, S.E.; GREGA, K.C.; HENDGES, S.K.;
TOOPS, D.S.; FORD, C.W. & ZURENKO, G.E. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J. Med. Chem., 39: 680-685, 1996.
2. CAMPOS, Y.; ERAZO, S. & DURÁN, N. Novos Fotoprodutos com Atividade Antimicrobiana de Chromobacterium violaceum. Arq. Biol. Tecnol., 25:147, 1982.
3. CENTERS FOR DISEASE CONTROL AND PREVENTION. Estimates of future global tuberculosis morbity and mortality. Morb. Mort. Weekly Rep., 39:1542-1545, 1995.
4. COHN, D.L.; BUSTREO, F. & RAVIGLIONE, M.C. Drug resistant tuberculosis: review of the world wide situation and the WHO/IUATLD Global Surveillance Project. Clin. Infect. Dis., 24:S121-S130, 1997.
5. CYNAMON, M.H.; SPEIRS, RJ. & WELCH, J.T. In vitro antimycobacteria1 activity of 5Chloropyrazinamide. Antimicrob. Agents Chemother., 42:462-463, 1998.
6. DEMOSS, RD. Violacein. Antibiotics. 2: 77-81, 1967.
7. DURÁN, N & HAUN, M. Processo de produção, obtenção, purificação e atividade antitumoral de 3-[1,2-Dihidro-5-(5-hidroxi-1-H-indol-3-il)2-oxo-3-H-pirrol-3-ilideno] 1,3-dihidro-2Hindol-Z-ona. PI 9702918-1, 1997.
8. DURÁN, N. & FALJONI-ALARIO, A. Bacterial Chemistry- I: Studies of a Potential Phototherapeutic Substance from Chromobacterium violaceum. An. Acad. Brasil. Ciênc., 55: 297302, 1980.
9. DURÁN, N. ERAZO, S. & CAMPOS, Y. Bacterial Chemistry-Il: Antimicrobial photoproduct from pigment of Chromobacterium violaceum. An. Acad. Brasil. Ciênc., 55: 231-234, 1983.
10. DURÁN, N.; CAMPOS, Y.; RIVEROS, R; JOYAS, A.; PEREIRA, M.F. & HAUN, M. Bacterial Chemistry-III: Preliminary Studies on Trypanosomal Activities of Chromobacterium violaceum. An. Acad. Brasil. Ciênc., 61:31-36, 1989.
11. ERICKSSON, H.M. & SHERIS, J.C. Antibiotic sensitivity testing: report for an international collaborative study. Acta Pathol. Microbiol. Scand. [B]Suppl., 217:3-90, 1971.
12. HART, C.A; BEECHING, N.J. & DUERDEN, B.I. Tuberculosis into the next century. J. Med. Microbiol., 44: 1-34, 1996.
13. KOCHI, A. The global tuberculosis situation and the new control strategy of the world Health Organization. Tubercle, 72: 1-6, 1991.
14. LICHSTEIN, H.C. & VAN DE SAND, Y.F.J. Violacein, an antibiotic pigment produced by Chromobacterium violaceum. J. Infect. Dis., 76:47-51, 1945.
15. LICHSTEIN, H.C. & VAN DE SAND, Y.F. The antibiotic activity of violacein, prodigiosin, and phthiocol. J. Bacteriol., 52: 145-146, 1946.
16. LIMA, M.M.; BELLUOMINI, M.; ALMEIDA, M.M.M. & ARANTES, G.R. Co-infecção HIV/tuberculose: necessidade de uma vigilância mais efetiva. Rev. Saúde Públ. S. Paulo, 31:217-20,1997.
17. MUSSER, J .M. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev., 8: 496-514, 1995.
18. PARKER, W.L.; RATHNUM, M.L. & JOHNSON, J .H. Aerocyanidin, a new antibiotic produced by Chromobacterium violaceum. J. Antibiot., 41: 454-460, 1988.
19. REITTORI, D. & DURÁN, N. Production, extraction, and purification of violacein: an antibiotic pigment produced by Chromobacterium violaceum. World J. Microbiol. Biothecn.i: in press.
20. SINGH, P.D.; LIU, w.c., GOUGOUTAS, J.Z.; MALLEY, M.F.; PORUBCAN, M.A.; TRElO, W.H.; WELLS, J.S. & SYKES, R. B. Aerocavin, a new antibiotic produced by
Chromobacterium violaceum. J. Antibiot., 41: 446-453, 1988.
21. SNIDER, D. E. & ROOPER, W. L. The new tuberculosis. N. Engl. 1. Med., 326: 703-705, 1992.
22. TSUKAMURA. M. In vitro bacteriostatic and bactericidal activity of isoniazid on the Myco-bacterium avium-Mycobacterium intracellulare complexo Tubercle,71:199-204, 1990.
23. UEDA, H.; MANDA, T.; MATSUMOTO, S.; MUKUMOTO, S.; NISHIGAK1, F.; KAWAMURA,!. & SHIMOMURA, K. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968:III. Antitumor activities on experimental tumors in mice. J. Antibiot., 47:315-323, 1994.
24. WAKSMAN, S.A.; BUGIE, E. & SCHATZ, A. Isolation of antibiotic substance from soil microorganisms with special reference to streptothricin and streptomicin. Mayo Clin Proc., 19: 537-548, 1944.
TOOPS, D.S.; FORD, C.W. & ZURENKO, G.E. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J. Med. Chem., 39: 680-685, 1996.
2. CAMPOS, Y.; ERAZO, S. & DURÁN, N. Novos Fotoprodutos com Atividade Antimicrobiana de Chromobacterium violaceum. Arq. Biol. Tecnol., 25:147, 1982.
3. CENTERS FOR DISEASE CONTROL AND PREVENTION. Estimates of future global tuberculosis morbity and mortality. Morb. Mort. Weekly Rep., 39:1542-1545, 1995.
4. COHN, D.L.; BUSTREO, F. & RAVIGLIONE, M.C. Drug resistant tuberculosis: review of the world wide situation and the WHO/IUATLD Global Surveillance Project. Clin. Infect. Dis., 24:S121-S130, 1997.
5. CYNAMON, M.H.; SPEIRS, RJ. & WELCH, J.T. In vitro antimycobacteria1 activity of 5Chloropyrazinamide. Antimicrob. Agents Chemother., 42:462-463, 1998.
6. DEMOSS, RD. Violacein. Antibiotics. 2: 77-81, 1967.
7. DURÁN, N & HAUN, M. Processo de produção, obtenção, purificação e atividade antitumoral de 3-[1,2-Dihidro-5-(5-hidroxi-1-H-indol-3-il)2-oxo-3-H-pirrol-3-ilideno] 1,3-dihidro-2Hindol-Z-ona. PI 9702918-1, 1997.
8. DURÁN, N. & FALJONI-ALARIO, A. Bacterial Chemistry- I: Studies of a Potential Phototherapeutic Substance from Chromobacterium violaceum. An. Acad. Brasil. Ciênc., 55: 297302, 1980.
9. DURÁN, N. ERAZO, S. & CAMPOS, Y. Bacterial Chemistry-Il: Antimicrobial photoproduct from pigment of Chromobacterium violaceum. An. Acad. Brasil. Ciênc., 55: 231-234, 1983.
10. DURÁN, N.; CAMPOS, Y.; RIVEROS, R; JOYAS, A.; PEREIRA, M.F. & HAUN, M. Bacterial Chemistry-III: Preliminary Studies on Trypanosomal Activities of Chromobacterium violaceum. An. Acad. Brasil. Ciênc., 61:31-36, 1989.
11. ERICKSSON, H.M. & SHERIS, J.C. Antibiotic sensitivity testing: report for an international collaborative study. Acta Pathol. Microbiol. Scand. [B]Suppl., 217:3-90, 1971.
12. HART, C.A; BEECHING, N.J. & DUERDEN, B.I. Tuberculosis into the next century. J. Med. Microbiol., 44: 1-34, 1996.
13. KOCHI, A. The global tuberculosis situation and the new control strategy of the world Health Organization. Tubercle, 72: 1-6, 1991.
14. LICHSTEIN, H.C. & VAN DE SAND, Y.F.J. Violacein, an antibiotic pigment produced by Chromobacterium violaceum. J. Infect. Dis., 76:47-51, 1945.
15. LICHSTEIN, H.C. & VAN DE SAND, Y.F. The antibiotic activity of violacein, prodigiosin, and phthiocol. J. Bacteriol., 52: 145-146, 1946.
16. LIMA, M.M.; BELLUOMINI, M.; ALMEIDA, M.M.M. & ARANTES, G.R. Co-infecção HIV/tuberculose: necessidade de uma vigilância mais efetiva. Rev. Saúde Públ. S. Paulo, 31:217-20,1997.
17. MUSSER, J .M. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev., 8: 496-514, 1995.
18. PARKER, W.L.; RATHNUM, M.L. & JOHNSON, J .H. Aerocyanidin, a new antibiotic produced by Chromobacterium violaceum. J. Antibiot., 41: 454-460, 1988.
19. REITTORI, D. & DURÁN, N. Production, extraction, and purification of violacein: an antibiotic pigment produced by Chromobacterium violaceum. World J. Microbiol. Biothecn.i: in press.
20. SINGH, P.D.; LIU, w.c., GOUGOUTAS, J.Z.; MALLEY, M.F.; PORUBCAN, M.A.; TRElO, W.H.; WELLS, J.S. & SYKES, R. B. Aerocavin, a new antibiotic produced by
Chromobacterium violaceum. J. Antibiot., 41: 446-453, 1988.
21. SNIDER, D. E. & ROOPER, W. L. The new tuberculosis. N. Engl. 1. Med., 326: 703-705, 1992.
22. TSUKAMURA. M. In vitro bacteriostatic and bactericidal activity of isoniazid on the Myco-bacterium avium-Mycobacterium intracellulare complexo Tubercle,71:199-204, 1990.
23. UEDA, H.; MANDA, T.; MATSUMOTO, S.; MUKUMOTO, S.; NISHIGAK1, F.; KAWAMURA,!. & SHIMOMURA, K. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968:III. Antitumor activities on experimental tumors in mice. J. Antibiot., 47:315-323, 1994.
24. WAKSMAN, S.A.; BUGIE, E. & SCHATZ, A. Isolation of antibiotic substance from soil microorganisms with special reference to streptothricin and streptomicin. Mayo Clin Proc., 19: 537-548, 1944.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 1999 Instituto Adolfo Lutz Journal
Downloads
Download data is not yet available.